RAJKUMAR VENKATRAMANI to Dactinomycin
This is a "connection" page, showing publications RAJKUMAR VENKATRAMANI has written about Dactinomycin.
Connection Strength
0.400
-
Addition of temsirolimus to chemotherapy in children, adolescents, and young adults with intermediate-risk rhabdomyosarcoma (ARST1431): a randomised, open-label, phase 3 trial from the Children's Oncology Group. Lancet Oncol. 2024 Jul; 25(7):912-921.
Score: 0.234
-
Congenital spindle cell rhabdomyosarcoma. Pediatr Blood Cancer. 2019 11; 66(11):e27935.
Score: 0.166